Drugs
Bioterrorism, drug preparedness and natural disaster response
Drug Approvals and DatabasesDrug-Related Databases from FDA; Information on Drug Approvals
Drug Safety and AvailabilityMedication Guides, Drug Shortages, Public Health Advisories and Other Safety Announcements
Development & Approval Process (Drugs)Conducting Clinical Trials, Types of Drug Applications, Forms and Submissions Requirements
Guidance for Industry, Warning Letters, Postmarket Surveillance Programs
News & EventsWhat's New on This Site, Drug Approval Listing, Meetings and Conferences
Science & Research (Drugs)Research by FDA Staff to Evaluate and Enhance the Safety of Drug Products
Resources for YouFor Consumers, Health Professionals, Industry
News and Announcements
- CellCept (mycophenolate mofetil) August 2009
Cases of Pure Red Cell Aplasia (PRCA) have been reported in patients treated with CellCept. Posted 08/14/2000 - Dextroamphetamine, Amphetamine 20mg Tablets
Recalled because the affected lot may contain some tablets exceeding weight requirements which may lead to super-potent tablets. Posted 08/14/2009 - Final Rules for Expanded Access to Investigational Drugs for Treatment Use and Charging for Investigational Drugs
Drug Safety
Spotlight
Recalls & Alerts
Contact Us
- (888) 463-6332
- (301) 796-3400
- druginfo@fda.hhs.gov
Human Drug Information
Division of Drug Information (CDER)
Office of Training and Communication
WO51-2201
10903 New Hampshire Avenue
Silver Spring, MD 20993